1.A Case of Woringer Kolopp Disease Treated with Topical PUVA.
Jae Bong LEE ; Ho Sun JANG ; Chang Keun OH ; Kyung Sool KWON ; Tae Ahn CHUNG
Korean Journal of Dermatology 1999;37(2):239-243
A 26-year-old Korean man had an erythematous scaly plaque on his right thigh for fifteen years. He was diagnosed with chronic eczema and treated with topical steroid, but no clinical improvement was obtained for 15 years. Laboratory studies including complete blood cell count, urinalysis, liver and renal function test, and peripheral blood smear were normal. A biopsy specimen showed hyperkeratosis, acanthosis, and mononuclear cellular infiltration in the epidermis. These cells had a perinuclear halo and showed a Pautrier's microabscess like configuration. In the dermis, there was a band like infiltration of inflammatory cells. Infiltrates of the epidermis were negative for leukocyte common antigen(CD45) and positive for Pan T cell(CD45RO). He was treated with topical PUVA twice a week for twelve weeks. Clinical and pathological improvements were obtained. We propose PUVA may be a useful therapeutic modality to treat Woringer Kolopp disease.
Adult
;
Biopsy
;
Blood Cell Count
;
Dermis
;
Eczema
;
Epidermis
;
Humans
;
Leukocytes
;
Liver
;
Pagetoid Reticulosis*
;
Thigh
;
Urinalysis
2.Urodynamic Findings in Diabetic Cytopathy.
Je Woong RYU ; Dong Deuk KWON ; Bong Ryoul OH ; Soo Bang RYU
Korean Journal of Urology 2000;41(1):105-109
No abstract available.
Urodynamics*
3.CS-3000 Plus Cell Separator; A-35 Collection Chamber vs PLT-30TM Collection Chamber.
Oh Hun KWON ; Hyun Ok KIM ; Seun Moo LEE ; Hee Bong SHIN ; Chun Hyun NAHM
Korean Journal of Blood Transfusion 1996;7(1):49-55
BACKGROUND: Recently, it has been established that plateletpheresis needs more efficiency and shorter processing time. Fenwall laboratories developed a new collection chamber for CS-3000 Plus, PLT-30TM collection chamber, which can reduce the processing time with efficient collection. We evaluated the PLT-30TM collection chamber by comparing it with A-35 collection chamber that has been used as a standard collection chamber of CS-3000 Plus us. METHODS: Thirty platelet collection procedures were performed using the CS 3000 Plus with A-35 collection chamber and PLT-30TM collection chamber. The changes of the hematologic parameters between pre- and post-donation in donors and the total platelets yields and the contaminated WBCs in the plateletpheresis products were evaluated. In processing, the yield predictor calibration was adjusted to 1.00 and 1.13 in A-35 and PLT-30TM respectively. Yield predictors of pheresis were the same as 3.5x1011 in both and end point volumes were calculated from the CS-3000 Plus. Processing volume and processing times were compared between A-35 and PLT-30TM groups. RESULTS: With PLT-30TM collection chamber, 3.38+/-0.72x1011/L platelets were harvested, whereas 3.20+/- 0.73x1011/L were collected with A-35 collection chamber, which was not significantly different. But processing time with the PLT-30TM collection chamber was more reduced than that with the A-35 collection chamber by about 20 minutes (PLT-30TM : 88.6+/-8.4 min, A-35 : 106.7+/-11.7min). Collection efficiency of PLT-30TM chamber was 50.7+/-12.5% and that of A-35 chamber was 44.4 + 8.8%. The leukocyte contamination of the platelet concentrates were not statistically different(PLT-30TM: 0.0-3.6x106, A-35 : 0.1-4.1x106). CONCLUSIONS: PLT-30TM collection chamber has the advantages of shortening the donation time and decreasing the processing volume with better collection efficiency and flexibility of platelet concentrate volume.
Blood Component Removal
;
Blood Platelets
;
Calibration
;
Humans
;
Leukocytes
;
Plateletpheresis
;
Pliability
;
Tissue Donors
4.Expression of Neuroendocrine Cells in Benign Prostatic Hyperplasia and the Effect of Dihydrotestosterone .
Sung Joon HONG ; Soo Mee KWON ; Sun Il KIM ; Hea Young OH ; Bong Chul CHUNG
Korean Journal of Urology 2003;44(3):267-271
PURPOSE: Neuroendocrine (NE) cells of the prostate are considered to be involved in the pathogenesis of benign prostate hyperplasia (BPH). By a comparative analysis of NE cell density in BPH tissue of men who were either exposed to or not exposed to 5alpha-reductase inhibitor, we investigated the relationship between NE cells and BPH, and the effect of androgen deprivation on NE cells. MATERIALS AND METHODS: Prostate tissue specimens, obtained from 30 men by transurethral resection of the prostate or radical cystoprostatectomy, were used. Of the 30 patients, 10 had a prostate smaller than 25 ml (normal control), the other 20 had a prostate larger than 40ml, 10 of who had taken 5alpha-reductase inhibitor (finasteride) for 3 months before surgery (androgen blockade group), and 10 who had not (BPH group). The distribution of NE cells in the prostate was examined using the anti-chromogranin A (CgA) antibody, and the density of the CgA-positive cells was compared by an optical dissector method. Immunoblotting was performed using the neuron specific enolase (NSE) antibody. A Mann-Whitney U test was used in a statistical analysis. RESULTS: Most of the CgA-positive NE cells were localized between the acinar epithelial cells. The mean numbers of CgA-positive NE cells per acinus in the normal controls and the BPH groups were 1.67+/-0.78 and 4.45+/-2.54, respectively, and the difference was statistically significant (p<0.05). However, the mean number of CgA-positive NE cells in the androgen blockade group, was 4.93+/-2.17, which was similar to the BPH group. In a NSE immunoblotting study, a distinct band was observed in the BPH and androgen blockade groups, but the density of the band was higher in the androgen blockade group. CONCLUSIONS: Our results suggest that NE cells may be involved in the hyperplastic process of BPH. Inhibition of dihydrotestosterone, caused by the oral administration of the 5alpha-reductase inhibitor, failed to induce any significant change in the NE cells, probably due to the incomplete androgen blockade.
Administration, Oral
;
Cell Count
;
Dihydrotestosterone*
;
Epithelial Cells
;
Humans
;
Hyperplasia
;
Immunoblotting
;
Male
;
Neuroendocrine Cells*
;
Phosphopyruvate Hydratase
;
Prostate
;
Prostatic Hyperplasia*
5.Apoptosis and Expression of bcl-2, p53, and Ki-67 in Mycosis Fungoides.
Jae Bong LEE ; Ho Sun JANG ; Chang Keun OH ; Kyung Sool KWON ; Jung Hum PARK
Korean Journal of Dermatology 1999;37(5):603-609
BACKGROUND: Mycosis fungoides(MF) is a form of cutaneous T cell lymphoma with clonal differentiation of helpr' T cell. It has a patch, plaque, and tumor stage. But pathogenetic factors controlling the development and progression of MF are still unclear. Apoptosis plays a major role in developmental biology and homeostasis. The bcl-2 oncogene prolongs ce11 life by inhibiting apoptosis. The mutant pS3 gene induces apoptosis indirectly. Ki-67 antigen is the cell proliferation marker. Recently, it has been shown that the relationships among them are important in the tumorigenesis of the various tumors. OBJECTIVE: The aim of this study was to examine the expression of these genes and apoptotic rate and clarify the relationship among them in the development and progression of MF. METHODS: The eighteen specimens from 8 patients with MF and 10 specimens from benign lymphocytic infiltrating diseases including 5 lichen planus, 3 lupus erythematosus, and 2 contact dermatitis were included. We performed immunoperoxidase staining(LSAB technique) using monoclonal antibodies including bc1-2, p~53, and Ki-67(MIB1). We used ApoptaqTM(Oncor) in situ labelling kit for detecting apoptotic cell.
Antibodies, Monoclonal
;
Apoptosis*
;
Carcinogenesis
;
Cell Proliferation
;
Dermatitis, Contact
;
Developmental Biology
;
Homeostasis
;
Humans
;
Ki-67 Antigen
;
Lichen Planus
;
Lymphoma, T-Cell, Cutaneous
;
Mycosis Fungoides*
;
Oncogenes
7.RFLP Analysis of a Gene for Blood Coagulation Factor IX in Korean.
Moosik KWON ; Jeong Min LEE ; Bong Kyun JEON ; Sung Gwan OH ; Chong Suk RYOU ; Bo Hoon OH
Korean Journal of Obstetrics and Gynecology 2001;44(3):506-512
OBJECTIVE: The purpose of this study was to investigate the methods for analysis of restriction fragment length polymorphisms of hemophilia B (coagulation factorIX) gene in Korean population. METHODS: Genomic DNAs were extracted from 40 Korean females. In order to amplify genomic DNAs at the region of the polymorphic sites, two sets of primers (Hha I and Dde I) were synthesized. The primers were named as FIX1, FIX2 for Hha I, and Dde I 59, Dde I 39 for Dde I, respectively. Hha I primers annealed 3'-flanking region of the FactorIX gene and amplified 230 bp long fragment. The PCR fragment (230 bp) treated with Hha I endonuclease produced two fragments (150 bp and 80 bp), when the polymorphic site existed. Dde I primers annealed the region of the first intron of Factor IX gene and amplified 319 bp long fragments. People cases with Dde I polymorphic site are supposed to produce 369 bp long fragment. Results: It has been found that seven (14 X chromosomes) out of forty individuals showed Hha I polymorphism. However, none of the experimental People cases showed the Dde I polymorphism. CONCLUSIONS: By the analysis of 80 chromosomes, the PICs calculated from allele frequency of Hha I-RFLP (0.175/0.825) and that of Dde I-RFLP (0.0/1.0) were 0.289=[1-(0.1752+0.8252)] and 0=[1-(02+12)], respectively. From these results, it can be postulated that Hha I and Dde I polymorphisms of the Factor IX gene in Korean exhibited different patterns from those of Caucasian.
Blood Coagulation Factors*
;
Blood Coagulation*
;
Dichlorodiphenyl Dichloroethylene
;
DNA
;
Factor IX*
;
Female
;
Gene Frequency
;
Genes, vif*
;
Hemophilia B
;
Humans
;
Introns
;
Polymerase Chain Reaction
;
Polymorphism, Restriction Fragment Length*
8.A Case of Tufted Angioma Arising within a Nevus Flammeus.
Hyun Woo CHIN ; Jae Bong LEE ; Bong Seok JANG ; Moon Bum KIM ; Chang Keun OH ; Ho Sun JANG ; Kyung Sool KWON ; Yoo Wook KWON
Korean Journal of Dermatology 2005;43(10):1439-1442
Tufted angioma is an uncommon, slowly-progressive vascular tumor, found typically in infants, young children and sometimes at birth or during adulthood. It shows a characteristic histopathologic finding, the so-called "cannonball" appearance. Various tumors can be developed in the nevus flammeus, such as pyogenic granuloma, basal cell carcinoma, squamous cell carcinoma, giant proliferative hemangioma and lymphangioma circumscriptum. Tufted angioma can be also accompanied with nevus flammeus and the coexistence of tufted angioma and nevus flammeus is a very rare condition. We report a case of tufted angioma arising within nevus flammeus in the left axilla of a 47 year-old female.
Axilla
;
Carcinoma, Basal Cell
;
Carcinoma, Squamous Cell
;
Child
;
Female
;
Granuloma, Pyogenic
;
Hemangioma*
;
Humans
;
Infant
;
Lymphangioma
;
Middle Aged
;
Nevus*
;
Parturition
;
Port-Wine Stain*
9.Prognostic Value of Peak Flow Rate and Post Void Residual Urine Measured by Abdominal Compressing Immediately after TURP.
Sang Hyun OH ; Byung Seok OH ; Kyung Dae MIN ; Dong Deuk KWON ; Bong Ryoul OH ; Soo Bang RYU
Korean Journal of Urology 2003;44(5):414-418
PURPOSE: Although a transurethral resection of the prostate (TURP) is the most effective treatment method for benign prostatic hyperplasia (BPH), it is difficult to predict the exact prognosis with this method. The peak flow rate (PFR) and post void residual urine (PVR), measured by abdominal compressing immediately after TURP in the operating room, were evaluated to see if they correlated with the surgical outcome. MATERIALS AND METHODS: Fifty patients, having undergone TURP, had their PFR and PVR measured by abdominal compressing, both before and after TURP in the operating room. The abdomen was compressed to 100cm H2O of intravesical pressure with a concrete test hammer. All patients were requested to undergo uroflowmetry, and their international prostate symptom scores (IPSS) were assessed, 3 months after surgery. RESULTS: The PFR and PVR, measured by abdominal compressing immediately after TURP, correlated well with the PFR measured 3 months after the TURP (p<0.05). Higher PFR, lower PVR and a greater improvement in the IPSS were observed, but these were not statistically significant. CONCLUSIONS: In conclusion, the PFR and PVR, measured by abdominal compressing immediately after TURP, are thought to be a good parameter for predicting the prognosis of TURP.
Abdomen
;
Humans
;
Operating Rooms
;
Prognosis
;
Prostate
;
Prostatic Hyperplasia
;
Transurethral Resection of Prostate*
10.Urinary Nuclear Matrix Protein ( NMP 22 ) in the Detection of Transitional Cell Carcinoma of the Bladder.
Soo Bang RYU ; Bong Ryoul OH ; Soon Pal SUH ; Dong Deuk KWON ; Je Woong RYU ; Yang Il PARK
Journal of the Korean Cancer Association 1998;30(2):378-383
PURPOSE: The detection of bladder cancers by noninvasive techniques remains an unsolved problem. We evaluate the availability of an immunoassay for urinary nuclear matrix protein, NMP 22, as an indicator for transitional cell carcinoma of the bladder. MATERIALS AND METHODS: Three groups of subjects participated in this trial of NMP 22: 22 patients with transitional cell carcinoma (group 1), 12 patients with urinary tract infection (group 2) and 31 healthy volunteers (group 3). NMP 22 was determined by ELISA using a commercial test kit (NMP 22 Test Kit, Matritech Inc., USA), We compared urinary NMP 22 levels to the grade, stage, cytology and DNA flowcytometry of transitional cell carcinoma of bladder. RESULTS: NMP 22 values in these 3 groups were significantly different (group 1, median 24.81 U/mL; group 2, median 8.41 U/mL; and group 3, median 5.12 U/mL; Mann-Whitney U test for differences between 3 medians, p < 0.05). The patients with transitional cell carcinoma had significantly greater urinary NMP 22 levels than those with no evidence of tumor (Mann-Whitney U test for differences between 2 medians, p<0.01). There was no zelationship between the urinary NMP 22 levels and tumor grade, stage, cytology or DNA flowcytometry. CONCLUSIONS: It is possible that urinary NMP 22 could improve the detection of bladder transitional cell carcinoma.
Carcinoma, Transitional Cell*
;
DNA
;
Enzyme-Linked Immunosorbent Assay
;
Healthy Volunteers
;
Humans
;
Immunoassay
;
Nuclear Matrix*
;
Urinary Bladder Neoplasms
;
Urinary Bladder*
;
Urinary Tract Infections